FDA Rejects Teplizumab for Type 1 Diabetes Delay FDA Rejects Teplizumab for Type 1 Diabetes Delay

The decision follows narrow endorsement by an advisory panel.Medscape Medical News

Source: Medscape Pediatrics Headlines - July 7, 2021 Category: Pediatrics Tags: Diabetes & Endocrinology News Source Type: news